SCHEMBL1214846

SCHEMBL1214846

CCCC(C)OC(=O)OC(C)CN[C@@H](Cc1ccc(OC(=O)CC(C)C)c(OC(=O)CC(C)C)c1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.52
ALDH1A1 P00352 1/20 0.36
LDHA P00338 1/20 0.34
REN P00797 3/20 0.34
ATM Q13315 1/20 0.33
CTSD P07339 1/20 0.33
BACE1 P56817 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2C P18825 1/20 0.33
DRD1 P21728 1/20 0.33
ADRA1A P35348 1/20 0.33
DRD3 P35462 1/20 0.33
PPARG P37231 2/20 0.32
PTGES O14684 1/20 0.32
ALOX5 P09917 1/20 0.32
FOLH1 Q04609 1/20 0.32
TRPV1 Q8NER1 1/20 0.31
FPR2 P25090 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1212068 0.94 ALOX15 (0.47) ALOX15ALDH1A1LDHARENATM
SCHEMBL1216046 0.92 ALOX15 (0.42) ALOX15ALDH1A1LDHAATMCTSD
SCHEMBL1213433 0.92 ALOX15 (0.54) ALOX15ALDH1A1LDHAATMADRB2
SCHEMBL1215385 0.92 ALOX15 (0.52) ALOX15ALDH1A1LDHAATMADRB2
SCHEMBL1215891 0.92 ALOX15 (0.44) ALOX15ALDH1A1LDHAATMADRB2
SCHEMBL1216913 0.91 ALOX15 (0.51) ALOX15RENADRB2ADRA2ADRD2
SCHEMBL1215567 0.91 ALOX15 (0.47) ALOX15ALDH1A1LDHAATMADRB2
SCHEMBL1215261 0.91 ALOX15 (0.55) ALOX15ALDH1A1LDHAATMADRB2
SCHEMBL1215271 0.91 ALOX15 (0.43) ALOX15ALDH1A1LDHAATMADRB2
SCHEMBL1215329 0.91 ALOX15 (0.55) ALOX15ALDH1A1LDHAATMADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028544-A1 CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE XENOPORT, INC. (US) 2011-02-03 US disclosed
US-7829592-B2 Catechol protected levodopa diester prodrugs, compositions, and methods of use XENOPORT, INC. (US) 2010-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028544-A1 CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE COMT, PARK7, DDT ALOX15 513/4885ALDH1A1 636/4885LDHA 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.